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ABSTRACT 
Commercialization of Research and Development (R&D) Products, 
particularly bioinformatics and biotechnology has always being 
overlooked by the industry and academic sectors. There are some 
misleading concepts that triggers both these sectors that 
commercialization of R&D products is not as part of their 
responsibilities. This is because the knowledge of R&D products 
emerges from academic world while commercialization involves 
business oriented field. This article is produced based on reference of 
various papers on commercialization of R&D products in Malaysia. 
Highlights of this article is to enlighten the current efforts and 
challenges faced by Malaysia in promoting R&D, specifically 
bioinformatics and biotechnology products, and produce thoughtful 
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discussion in improving the current effort. 
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1. INTRODUCTION  
Biotechnology can be best defined as a technology focus on biology usage in agriculture, food science, 
and medicine (“The Convention on Biological Diversity”, 2006). Information technology carries the 
definition of an industry that uses computers, networking, software programming, and other tools and 
processes to store, process, retrieve, transmit, and protect information. As per illustrated by Figure 1, 
bioinformatics can be defined as an industry that uses information technology tools to study 
biotechnology data or findings. Therefore, biotechnology and bioinformatics field are dependent on 
each other. Malaysia has been working on this industry for more than two decades. There are rapid 
development observed in these two industries and it is a good prognosis for Malaysia to excel in 
Research and Development area (R&D).  R&D is an on-going investment and there is no limitation for 
the achievement. Malaysia involvement and investment in R&D, particularly biotechnology, stated with 
agricultural and then developed until it merges with information technology to initiates bioinformatics 
which makes the R&D industry more realistic and reliable.  
Innovating Malaysia (n.d.) states that even though open innovation has been a fifty years concept, only 
recently this concept was fully understood by government agencies and firms. This awareness on open 
innovation results on the registration of Malaysia as a member of National Biotechnology and 
Bioinformatics Network (NBBNet) in the year of 1999. Through this association, a Workbench named 
WebANGIS (MANGIS) was established to facilitate a nationwide network which supports bioinformatics 
and biotechnology researches (Zeti et al. 2009). Other than that, Malaysia also a participant of Asia-
Pacific Advanced Network (APAN) which works on the National Research and Education Networks 
(NRENs) in Asia. This network connects Asia to the United States of America through Transpac Project 
and to Europe through Trans-Eurasia Information Network (TEIN) (Ranganathan, S., 2005). This network 
creates borderless worlds which create opportunities for developing nations such as Malaysia to 
exchange information and be more innovative in the R&D area. 
The most recent APAN meeting, APAN-33rd meeting was held in Thailand from 13th February 2012 until 
17th February 2012. Several workshops, paper presentation and exchange of knowledge was organised 
through this community network (http://www.apan.net/meetings/ChiangMai2012).  
 
 BIOTECHNOLOGY INFORMATION 
TECHNOLOGY 
 
BIOINFORMATICS 
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Figure 1: Correlation between bioinformatics and biotechnology.  
Commercialization process in a research field starts from the recognition of opportunities, then continue 
with basic and applied research with creativity which leads to innovation. Basically the final stage in 
commercialization is entrepreneurship and commercialization (Farsi, J.Y. & Talebi, K., 2009). 
2. MALAYSIA’S CURRENT EFFORT IN BIOINFORMATICS AND BIOTECHNOLOGY 
2.1 Government Policies 
The progress of science and technology in Malaysia went through different phases. The First National 
Science and Technology Policy (NSTP1) were formulated in 1986 with the purpose of outlining a 
framework for science and technology development in Malaysia. NSTP1 aims to ensure the achievement 
of continuous scientific and technological development to accelerate economic growth, industrial 
development and creating high-tech (advanced) society (Chandran et al., 2005).  
Malaysia Plan which is structured in a 5 years basis is designed to achieve the nation’s vision which is on 
par with globalisation. As such the National Science and Technology Policy were incorporated into the 
Fifth Malaysia Plan (1986-1990). In 1991, The National Action Plan for Industrial Technology 
Development (TAP) was launched to specifically promote industrial technological development. 
However, STP1 and TAP was incapable of commercializing research outputs and lacked the techno-
entrepreneurship (Chandran & Wong, 2011).  
The Sixth Malaysia Plan (1991-1995) focuses on the market-orientated commercialization. Collaboration 
between government and private sectors are initialized to expand the R&D sector by providing basic 
infrastructure incentives and supporting services. The Seventh, Eighth and Ninth Malaysia Plan 
subsequently focus on economic growth and competitiveness by increasing productivity. One decade 
journey in R&D sector lead to the review of the science and technology policy in the year 2000 and 
subsequently the Second National Science and Technology Policy (STP II) was launched in the year 2003. 
The implementation of this plan is centralised by joint venture of government, industry, universities and 
public research institutions together in a synergistic partnership (Zain, 2010). 
Based on The Ninth Malaysia Plan, the National Biotechnology Policy was launched in 2005 to increase 
creation and innovation in the agriculture industry through biotechnology. The National Biotechnology 
Division (BIOTEK) under the Ministry of Science, Technology and Innovation (MOSTI) is responsible in 
enforcing the National Biotechnology Policy. There are nine thrusts included the development in 
different biotechnology field, human capital, financial infrastructure, strategy positioning, and 
government commitment. Biotechnology creates a sustainable bio-based economy. The policy is 
implemented in academic research, transfer of technology and industrial adoption. It envisions that 
biotechnology will be a new economic engine for Malaysia, enhancing the nation's prosperity and well-
being. Through the policy, the government has established BiotechCorp (Malaysian Biotechnology 
Corporation), a one-stop centre for biotechnology; and three national R&D institutes, namely the 
Malaysia Agro-Biotechnology Institute (ABI), Institute of Pharmaceutical and Nutraceutical Malaysia 
(IFNM) and Malaysia Genome Institute (GenoMalaysia). The policy also allows the government to 
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provide various fiscal and tax incentives to biotechnology companies (“Overview: Malaysian Agricultural 
Biotechnology”, 2009). 
2.2 Government Schemes and Policy Mechanisms 
Various initiatives and mechanisms have been introduced by the Government to promote the 
development of biotechnology and bioinformatics. One of such effort is providing grants and loans as 
well as incentives to promote and support research into the public sector, and encourage more private 
sector investment in new technologies. Ministry of Science, Technology and Innovation (MOSTI), 
Malaysian Technology Development Corporation (MTDC), and National Biotechnology Directorate (NBD) 
are some of the various governmental bodies which take lead in structuring the schemes for fund 
allocation. These agencies each have different objective, sector and activity focus (Krishna, 2006).  
Under MOSTI, the Industrial Research and Development Grant Scheme (IGS) was established with an 
initial allocation of RM100 million to promote market-oriented R&D and technology development 
projects involving the collaboration of the private sector, universities and research institutions. Based on 
Seventh Malaysia Plan (1996), the Commercialization of Research and Development Fund (CRDF) and 
Technology Acquisition Funds (TAF) were launched in 1997 and managed by Malaysian Technology 
Development Corporation (MTDC) with allocations of RM63 million and RM 118 million respectively. The 
allocation increases in the Eighth and Ninth Malaysia Plan to RM110 million and RM 250 million 
respectively. The objective is to accelerate and upgrade the development of indigenous technological 
capabilities, especially CRDF focuses on the commercialization of R&D findings undertaken by local 
universities and research institutions as well as companies and individual researchers and inventors.  
According to Malaysian Science & Technology Indicators 2008 Report (2008), several new schemes were 
introduced by the Malaysian Government in order to achieve the mission to harness Science, 
Technology and Innovation included the Malaysian Life Sciences Capital Fund (MLSCF), Biotechnology 
R&D Grant Scheme, ScienceFund, TechnoFund and Spectrum Research Collaboration Program (SRCP). In 
the Ninth Malaysia Plan, these funding are available and support the Research, Development and 
Commercialization (R&D&C) programs in different phases: creation, research, development, and 
commercialization (Fund Management Unit, MOSTI, n.d.). Table 1 showed the available grant schemes 
provided for Biotechnology field in Malaysia. 
 
Agency Type of Scheme Priority Areas 
Ministry of Science, 
Technology and 
Innovation (MOSTI) 
Intensification of Research in 
Priority Areas Grant Scheme 
(IRPA) 
R&D activities in line with national R&D 
priority areas 
Industry Research & 
Development Grant Scheme 
R&D in priority technology areas including 
biotechnology with prospects of 
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(IGS) commercialization 
Human Resource Development 
Fund (HRDF) 
Hands-on S&T training for researchers & 
officers at local research institutions & 
universities 
ScienceFund Carry out R&D projects that can acquire and 
generate new knowledge in strategic basic 
and applied sciences 
TechnoFund 
 Pre-commercialization 
 IP Acquisition 
Foster greater collaboration between 
Malaysian private entities and government 
research institutions of higher learning 
Malaysian 
Technology 
Development 
Corporation (MTDC) 
Technology Acquisition Fund 
(TAF) 
Acquisition of technology & licensing 
procurement; Acquisition of patent rights, 
prototypes & design 
Commersialisation of Research 
& Development Fund (CRDF) 
Market survey  & research; product or  
process design & development; standards & 
regulatory compliance & IP protection; 
demonstration of technology 
Business Growth Fund (BGF) Support and encourage entrepreneurship 
and creation of new strategic businesses that 
are important and potentially scalable, and 
the funding of supporting companies within a 
technology eco-system 
Malaysian Life Sciences Capital 
Fund (MLSCF) 
Biotechnology, pharmaceuticals, diagnostics, 
devices, human healthcare and related 
medical technologies, nutraceuticals and 
wellness, agricultural biotechnology, and 
industrial biotechnology 
(biomaterials/bioprocesses) 
Multimedia 
Development 
Corporation (MDC) 
Multimedia Super Corridor 
Research & Development Grant 
Scheme (MGS) 
R&D in products & services across 
multimedia value chain & the MSC 
application 
Malaysian Institute 
Microelectronic 
Demonstrator Application Grant IT & multimedia technology proposals & local 
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System (MIMOS) Scheme (DAGS) content with identified beneficiaries 
National 
Biotechnology 
Directorate (NBD) 
Biotechnology R&D Grant 
Scheme 
Research completed but still requires 
developmental research of data prior to 
commercialization i.e. scale-up of research 
findings to commercial level 
Bank Pertanian 
Malaysia 
Bank Pertanian Malaysia Fund 
for Food (BPM) 
Domestic projects where at least 50% of total 
production is sold in domestic market; 
projects involving primary food production 
(using animal husbandry, agriculture 
cultivation, fisheries & biotechnology), 
integrated agriculture & processing and/or 
distribution of food 
Malaysian 
Communications & 
Multimedia 
Commission (MCMC)  
Spectrum Research 
Collaboration Programme 
(SRCP)  
 
Promoting research collaboration between 
institutions of higher learning (IHL) and 
various other public and private sectors. 
 
Malaysian 
Biotechnology 
Corporation (MBC)  
Seeds Fund To finance start-up costs in setting up 
biotech companies and assist towards the 
development &commercialization of 
biotechnology projects in line with the 
objectives of the National Biotechnology 
Policy 
R&D Matching Fund  To provide matching fund for R&D projects 
to develop new or improved products and/or 
processes and/or technologies.  
International Business 
Development Matching Fund  
To provide matching fund for R&D projects 
to develop new or improved products and/or 
processes and/or technologies.  
 
Table 1: Biotechnology Grant Schemes in Malaysia. (Source from Malaysian Biotechnology Information 
Centre (MABiC), Malaysian Science & Technology Indicators 2008 Report) 
In an effort to commercialize research outcomes, the techno-infrastructure was strengthened by 
providing facilities to the private sector. Techno-infrastructures such as technology incubator centres 
were collaboratively set-up by Malaysian Technology Development Corporation (MTDC) and Technology 
Park Malaysia (TPM). MTDC also collaborates with local institutions of higher learning (IHL) to set up 
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incubation parks near the IHL to assist their start up ventures such as UPM-MTDC Technology Centre, 
UTM–MTDC Technology Centre and UKM-MTDC (Krishna, 2006). Establishment of TPM provides 
infrastructure services for technological innovation and R&D which enables knowledge based 
enterprises to grow and compete in the global marketplace. On top of that, it also facilitates 
government and private sectors smart partnerships in technology development.  
In addition, Bio-XCell in Iskandar Johor is a biotechnology park is a dedicated, purpose-built space and 
facilities for biotechnology companies. Bio-XCell has attracted substantial Foreign Direct Investment 
(FDI) leading global players such as Biocon Ltd, Metabolic Explorer SA and Glycos Biotechnologies Inc. 
with a total approved investment of RM1.146 billion (approximately USD 370 million) (Italia, 2011). 
BioNexus is a special status awarded to qualified international and Malaysian biotechnology companies. 
The status endows fiscal incentives, grants and other guarantees to assist growth. Since 2005, the 
BiotechCorp has facilitated the development of 207 BioNexus status companies in Malaysia with total 
approved investment of RM 2.118 billion. The BiotechCorp also provides a wide range of capacity 
building programs covering a variety of subjects to assist biotechnology entrepreneurs in managing their 
business locally and internationally (http://www.biotechcorp.com.my/). 
The National Science and Research Council (NSRC) was proposed under Tenth Malaysia Plan to improve 
the governance of R&D, to have a move on S&T priorities through an effective network of all 
government research institutes and facilities and to monitor the impact of sectorial R&D productivity in 
the effective implementation of the government’s plan for a high income economy (Pillai, 2011). This 
council which acts as an advisory body is comprised of high-level representatives from Ministries, 
Government Agencies, Universities, Industry and the Academy of Sciences and is supported by MOSTI. 
2.3 Private Sectors 
With the vast amounts of data and information being generated due to advance in myriad of 
technologies, Bioinformatics provides an important support function to manage, analysis, and distribute 
biological information derived from genome sequencing and functional analysis of research projects. In 
addition to become a new source of growth, bioinformatics is making significant contribution towards 
discoveries and biotechnology development. ICT platforms in research institutions including MIMOS, 
universities and the Multimedia Super Corridor (MSC) help in accelerating of the development of 
bioinformatics sector in Malaysia. In Ninth Malaysia Plan, the second phase of Malaysian Research and 
Education Network (MyREN) was initiated to enhance universities and research institutions, and 
industry with international linkages to increase collaboration efforts. 
Although Malaysia has just started its journey in the field of bioinformatics (early 1990’s), there are few 
bioinformatics companies which are doing well in this field. They are able to provide world class 
bioinformatics solutions (“Bioinformatics for Malaysia,” 2008). Some of the companies are: 
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i. Synamatix 
Founded in 2001- primary focus is on the research and development of customized bioinformatics and 
one of the first bioinformatics company to earn MSC status in Malaysia. Other than its focus on industry 
it also collaborates with educational institute to promote the growth of biotechnology and 
bioinformatics in Malaysia. One of such effort was done on January 2008 when Synamatix announced 
research collaboration on license of cutting- edge bioinformatics technology with University Malaysia 
Sabah’s Biotechnology Research Institute (BRI).  
ii. Malaysian Genomic Research Centre (MGRC) 
Subsidiary of Synamatix- provides Contract Genomics Services, Sequencing Services, and Data and 
Access Services- one of the Bio Nexus Status Company. MGRC is a well based bioinformatics company 
which gain the trust of Malaysian Government to carry out research projects. One of such effort is 
involvement in MyGenome Project which was awarded by Ministry of Science, Technology and 
Innovation (MOSTI). MGRC has remained profitable and expected to produce revenue in the future. This 
can be clearly illustrated in the table below: 
 
Table 2: Revenue Composition- 5 years. (Source: Annual report of MGRC for year June 2011) 
iii. Infovalley 
Started in the year of 2000, with the aim of becoming the powerhouse of life sciences by providing 
rationale solutions and create socio-economy value in Malaysia. The main line of business for these 
companies relies on bioinformatics, biotechnology and medical informatics. One of its valuable 
inventions is digital autopsy services. Besides, Infovalley is one of the leaders in providing medical and 
forensic tools to customers around the world in addition to bioinformatics solutions. Association of this 
company with the nation’s ICT lead Multimedia Development Corporation (MDeC) catalysts global 
marketing in high rate. Another wise move of Infovalley in the move of penetrate into global market is 
through association with world class companies such as Intel, Oracle, SGI, Illumina and GE Healthcare 
even from the beginning. Co-existence and co-branding had great a fundamental platform for the 
growth of infovalley (Stories of Innovative Entrepreneurship, 2009).   
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Development and achievement of these companies clearly indicates that Malaysia is moving the right 
way to commercialize bioinformatics and biotechnology products and services. Growth of bioinformatics 
industry will simultaneously trigger the growth of biotechnology industry as it works as a catalyst for the 
latter. 
 
Figure 2: Institutional Structure Supporting Innovation and R&D (Source: Malaysia Tenth Plan) 
2.4 Education 
Education is the base for the establishment of any industry. It provides the knowledge and produces the 
expertise to commercialize an industry. Any new venture of an industry to a nation’s market is 
technically based on the education frame of the nation. The same concept applies to bioinformatics and 
biotechnology industry. Currently, Malaysia’s education system is leading towards research based 
knowledge to produce innovative products and services. As for bioinformatics, it serves as a bridge for 
connecting biology and information technology. Basically industries invest in a new area of business 
based on the educational growth as it is the source of expertise. In the year of 2006, four public 
universities are designated as research universities; namely University Sains Malaysia (USM), University 
Malaya (UM), University Putra Malaysia (UPM) and University Kebangsaan Malaysia (UKM). University 
Technology Malaysia (UTM) was designated as a research university in 2010. This certification was 
granted to the universities as a move to encourage and focus on research works. An additional of RM 
100 million is allocated for each university for research, development and commercialization. There are 
twelve universities and colleges inclusive of UM, UPM and UKM offer Bioinformatics course at 
undergraduate and also higher level. Multidisciplinary criteria of this course attract various ranges of 
students who wish to apply their strength in a wide area. Crystal project was one of the efforts initiated 
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by UM in order to consolidate multidisciplinary research between life sciences and computational 
sciences. (http://educationmalaysia.blogspot.com) 
2.5 Collaboration 
The market-societal driven collaborative R&D commercialization model was introduced during the Third 
Islamic Economic Congress by University of Technology Malaysia in 2009. The relationship between 
universities, community and industry is vital for Malaysia’s development. They need to learn from and 
collaborate with each other.  Based on the model, universities play role in creating new knowledge and 
ideas in basic research. Applied research is being done collaboratively by academic institutions, such as 
universities, research agencies, and private sectors to do pilot study and simulation, and prototyping in 
development stage. Then it can be used to bring out new products in the market place in the 
collaboration with entrepreneurs and private sectors. 
Besides, the openness to foreign technologies and to cross-border cooperation in R&D will increase the 
capacity of Malaysia to absorb and adapt technologies developed worldwide. International 
collaborations between Malaysia and foreign institutions help to build a foundation for a sustainable 
agricultural biotechnology industry. Some of Malaysia’s local and foreign collaborative partners are 
shown in the Table 3 below.  
 
Table 3:  Local and International Collaboration, year 2009. (Source: Overview: Malaysian Agricultural 
Biotechnology) 
3. CHALLENGES IN COMMERCIALIZATION OF BIOINFORMATICS AND BIOTECHNOLOGY PRODUCTS  
3.1 Funding 
The level of biotechnology accomplishments in Malaysia is low compared to global standards. The 
Government should identify the factors that affect the level of adoption and development in Malaysian 
biotechnology innovation system and to define the predictors of level of innovations as perceived by 
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academic researchers. Farid et al. (2011) commented that the level of knowledge, level of cooperation, 
level of acceptance and amount of fund are effective factors that encourage adoption of biotechnology 
innovations from the perspective of university researchers. However, the amount of fund allocated to 
adopting companies by the government is the most powerful predictor of the increase of the level of 
adoption for both biotechnology companies and academic researchers (Farid et al. 2012). 
National surveys of innovation and R&D have been routinely carried out in Malaysia since mid-1990s. 
The surveys suggested that appropriate source of financing continues to be a serious problem for 
innovation firms (C., Lee & C-Ging, Lee, 2007). The government has responded to this problem by 
providing support in the form of direct financial grants and various tax incentives. Various studies show 
that the funds for these two industries basically come from government agencies (Chandran, 2010). 
Fund provided by government agencies only able to support a research project at a starter level and is 
not enough for commercialization. Other than that, there is lack of funding from banking institution. The 
available loans in banking sectors are not prone towards the starters in the field. Importance and trust is 
placed on the property owned by the researcher rather than the innovative ideas. According to Kassim 
(2009), Malaysia enjoys 52% of R&D funding from the private sector while 32% funding is still by the 
Government while compared to Japan and South Korea with almost 75% funding from the private 
sector. 
3.2 Education 
The number of graduates from public institutions from year 1994-2002 for first degree courses is shown 
in Figure 3. The chart clearly indicates that only small amount of students graduating from natural 
sciences and computer science field compared to social science and humanities field. Number of 
students in a field is an indicative of the available human resource in the respective field. This factor will 
indirectly cause the lack of expertise problem in the field of science generally and particularly in the field 
of biotechnology and bioinformatics. According to Dr Megawati Omar and Dr Abu Bakar, the number of 
Science stream students dropped by 29% since 2007 (“Where are we heading in research?”, 2012). For 
instance, a research group which is working on a DNA sequencing project should have depth knowledge 
on both experimental and analytical part of the studies. Lack of knowledge to apply bioinformatics tools 
will cause extra cost for the R &D group as they send the sequences to an external source for analysis. 
Malaysia’s stand in research field can well picture by considering number of citation per paper as it is 
the measurement of true quality research. For the past decade, Malaysia was able to produce 44000 
research papers lagging behind Singapore which produced 85000 research papers while Thailand 
managed to produce 49000 research papers. (StarEducate, 2012). 
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Figure 3: Graduation from Public Universities for First Degree Courses. (Source: This report has drawn 
from Ahmad, F. and Krishna, V.V. (2006); Malaysian websites on S&T and other sources. The draft is the 
outcome of collaboration with Dr Fadzilah Ahmad of MOSTI) 
Tenth Malaysia Plan emphasises the development of human capital to meet industry’s requirement to 
drive productivity improvements to move up the value chain. Public and private universities should work 
towards to achieve world class educational institution status. In order to produce a pool of talent and 
expertise in biotechnology and bioinformatics fields, various programmes should be implemented to 
increase the number of graduates in higher education. For example, National Science Fellowship 
programs provided scholarships to 156 Masters and PhD students in biotechnology-related fields (Ninth 
Malaysia Plan, 2006). Besides, MyMaster & MyPhD programmes were created under the 10th Malaysia 
Plan via MyBrain15 program for the sponsorship of postgraduate study at the Masters and PhD levels. 
Under this programme, the government aims to produce 60,000 PhD holders in Malaysia by the year 
2023 (https://payloan.mohe.gov.my/MyBrain15/index2.php).  
3.3 Lack of expertise  
Commercialization of a product in scientific field requires understanding of the product from even the 
management structure. Deep and correct understanding of a new product in research and development 
sector is crucial in order for the product to hit the market at the right time. This also will be a factor in 
the determination of the target market. Identifying the right target market will gear up the 
commercialization activities. This can best be illustrated at Technology Transfer Office (TTO) in 
universities which are responsible in the release of a product. It enable better liaison with the private 
sector and to facilitate business arrangements between the researchers and the private sector. This 
section is usually managed by academics that are lack of the expertise needed to scientific creations of 
the researchers (Chandran Govindaraju, 2010; Innovating Malaysia, n.d.). Not able to understand the 
mechanism of the product affects time lines and outcome of commercialization activity. R&D sector in 
Malaysia is still focus at the first generation stage where performing the experiments at laboratory level 
is given the top priority (Chandran Govindaraju, 2010). At first generation stage in research, most of the 
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time, funding and knowledge are drifted into the laboratory methodologies. Priority is given to produce 
the best product which can perform well at laboratory level but not commercially. This scenario is 
inversely proportional with countries in the West with the priority in R&D is evolved at the fourth 
generation where the priority given at the market needs in a very early stage (“The Convention on 
Biological Diversity,” 2006). There is always a gap exists between marketing and scientific field. This gap 
intrudes the commercialization activities of R&D products. 
There are many mechanisms for the technology transfer of research and technologies developed by 
local universities and research institutions.  For example, getting involved in an undergraduate research 
project or providing a placement for a student to get work experience. The mechanisms for the 
technology transfer of research are consultancy service, outright sale of technology, licensing of 
technology, joint-venture, and start-up ventures. 
3.4 Lack of collaboration 
Another aspect in hindering commercialization success of Bioinformatics and Biotechnology products is 
lack of university-industry linkage (Chandran, 2010) due to the unhealthy user-experience that the 
private sector encounters differs from what is term “best practices” to ”worst practices” (Innovating 
Malaysia,2011). The University and private sector still cannot work well due to different point of view 
and policies. In Malaysia, normally the research is referred to as “blue sky” research. It aims to 
discoveries of new breakthroughs but have no links to commercial or societal benefits. Generally, 
researchers and inventors do not make business people (Innovating Malaysia, 2011).  Innovating 
Malaysia states that commercialization success is more likely to come from the private sector, which 
understands the markets, distribution channels, sales and marketing strategies, along with efficient 
mass-production techniques and process. The Government plays a key role in forging linkages between 
the generators of knowledge and the users of knowledge. Innovating they should work hard in develop 
the linkage between academia and industry to achieve the higher success rate in Biotechnology and 
Bioinformatics products commercialization (Innovating Malaysia, n.d.). 
The Prime Minister Datuk Seri Najib Tun Razak stated that Malaysia is the first country to introduce 
Quadruple Helix strategy in its innovation ecosystem. The Quadruple Helix Model is an improvement on 
the “Triple Helix Model”, which popularised the interaction between industry, academia and 
government. Quadruple Helix Model adds another dimension that is equally important today as the 
other three – the Rakyat (“Quadruple Helix’ way to innovation”, 2012). The four segments of the helix 
work together in making Malaysia globally competitive.  
3.5 Intellectual Property (IP) 
Although the government undertakes various initiatives to accelerate the rate of commercialization by 
setting up institutions and programs, there still some challenges exist. The national progress in 
intellectual property (IP) and technology commercialization is low. Chandran & Wong (2011) indicates 
that the current local indigenous innovative capabilities are still weak and require better policy 
intervention to accelerate the inventive capabilities of Malaysia. 
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Patent data was obtained from the Malaysian Intellectual Property Association (MIPA) database. The 
real number of patent applications by foreign and local companies in Malaysia is showed in Figure 4. 
Overall, the patent applications over 1988-2012 is only 8.8% compared to the foreign companies’ 
application of 91%. The main reason of limited number of patent fillings by local companies is lack of 
understanding on the contribution of patents to the company’s performance and lack of knowledge on 
the importance of protecting intellectual property (IP). 
This is also restricted to Malaysia’s low investment in R&D and poor human capital development. 
Malaysia has to identify the R&D projects undertaken by universities and private research institutes that 
have commercial value, convert them to real wealth, through commercialization. These projects are 
typically embodied in commercially valuable Intellectual Property (IP). In addition, local companies were 
found to mainly engage in process technology and in product modification. In other words, they often 
engage in incremental innovation and not radical innovation. (Chandran & Wong, 2011).  
 
Figure 4: Patent applications by foreign and local companies in Malaysia (Source: Malaysian Intellectual 
Property Association (MIPA) database) 
4. BENCHMARKING, DISCUSSION AND IMPLICATION  
South Korea was once a poor nation. This is a good example of a country that was able to develop and 
become part of the world industry leaders. During the 1980s, South Korea rapidly expanded into 
information technology and in 1994, seven government ministries work on ‘Biotech 2000’ plan, to make 
South Korea as one of the world’s top seven biotechnology producing countries by 2010 (Wong et al., 
2004). South Korea increased its R&D intensity steadily and reached the level of an advanced country in 
1990s. The growth rate of R&D intensity by South Korea surpasses that of Japan and Taiwan, with the 
growth rate being especially high in the 1980s and the 1990s. However, it is only in the 1990s when 
Korean R&D efforts finally became comparable to developed countries, including Germany and France 
(Bartzokas, 2008). 
Funding and commercialization are two important dependant elements for South Korea. In a nutshell, it 
simply means that adequate funding will lead to successful commercialization. Malaysia Government 
has invested heavily in biotechnology and bioinformatics especially the Universities and public Research 
Institutes. Each 5-year Malaysia Plan has increased its R&D budget consecutively. Wong et al. (2004) 
revealed that the investment capital in South Korea is both abundant and smart. Due to the availability 
of capital resources, by year 2001, the private sector provided for nearly three-quarters of R&D 
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expenditures. On the other hand, Malaysia is still heavily relying on government funding. It is important 
for Malaysia to develop more funding organizations to ensure the government investment in innovation 
is efficiently and transparently allocated and also boost up the private sector’s role in venture funding. 
At the same time, the government disbursement agencies have to transform themselves and behave 
like fund managers where grants are treated as government investment capital in innovation 
(Innovation Malaysia, 2011) 
Besides as a growing nation, Malaysia’s funding has always been a challenge because it is easily 
influenced by the economic crisis faced by the developed nations. The recent economic crisis leads the 
growth of biotechnology industry muted, while lower the growth rate in bioinformatics industry.  Lack of 
risk taking attitude among the giants in private sector inhibits them from investing in researches based 
on bioinformatics and biotechnology. This is due to the uncertain outcomes from the field.  
In order to train scientists of top quality, the transformation of current teaching-oriented universities 
into research-commercialized-oriented universities is critical. In Malaysia, exam oriented education 
system also become a barrier for the innovative ideas among the students. Students in Malaysia are 
more focused on the need of passing the exam and get an ‘A’ rather than understand principles in a 
theory. Malaysian education system should aim at producing groom thinkers and not facts memoriser. 
As the Innovation Malaysia states that our graduate must master higher order thinking skills, as the 
foundation of innovation lies in one’s ability to think critically and analytically, constructively and 
analytically. In order to sustain in the field of research one need to invent and invention requires more 
thinking and not memorising (StarEducate, 2012). A student who was brought up in such situation is 
unable to produce innovative ideas as memorising facts as been a habit all the while. Malaysia should 
come out from the spoon-feed environment and trust the younger generation, can be a vital resource of 
this industry. There are high chances to produce world-class students if the educational institutions are 
based on world class status.  
One of such efforts is to engage the final year projects and R&D works with the industries. Applied R&D 
projects in universities have to be driven by market needs identified by the practitioners in the sector, 
coupled with the foresight in science and technology (innovating Malaysia, n.d.)   Therefore, higher 
education institutions should engage themselves with private sectors from the very beginning itself. 
After all, the purpose of an education is to produce human resource for the industries and government 
sectors. To stimulate such a transformation, the government is suggested to provide financial support to 
those universities with excellent research performance. Many of the major universities in Korea have 
responded to the government policy by preparing and launching various reform programs that are 
anticipated to bring about drastic changes in university education in Korea (Wong et al., 2004). In 
addition, entrepreneurial university which emphasises on university R&D commercialization and 
technology transfer is a good concept Malaysia should adopt in the process of enriching 
commercialization process. The commercialization process has three key aspects namely the 
opportunity, the exploitation process and the support community. An appropriate knowledge 
management (KM) which gives priority to creation, utilization and development of a tertiary institution’s 
business intelligence should be implemented via higher education system (“Application of Knowledge 
Management for Research Commercialization”, 2009). Figure 5 illustrates an example of knowledge 
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management flow suggested by Jahangir Yadollahi Farsi and Kambeiz Talebi in the paper Application of 
Knowledge Management for Research Commercialization. 
 
Figure 5: Knowledge Management Model for Research Commersialisation with  5 components: 
Academic entrepreneurial capability, inputs, processes, outputs and Feedback loop. 
To reduce the inherent risks in the biotechnology field, the South Korean industrial policy makers and 
private sector investors are focusing on creating enterprises that leverage on the country’s existing 
industrial competitive advantages in fields such as pharmaceuticals and information technology (Wong 
et al., 2004). Malaysia has a strong foundation agriculture base and leading the production of industrial 
crops, for example oil palm, rubber, cocoa, pepper and tropical timber.  Malaysia has taken similar 
approach by focusing on agricultural biotechnology as one of the key to boost the level of 
commercialization of R&D products through the development of a public financed research system. This 
is an investment to enhance the innovative capacity of the national biotechnology research program, 
and creation of institutions and regulations. 
On the other hand, South Korea-based scientists collaborate with researchers from other countries. 
Because of the policy swift in South Korea, the amount of foreign direct investment in Biotechnology 
field was tripled between year 1997 and 2001. According to Wong et al. (2004), South Korea 
biotechnology firms participate in transnational collaborative linkages in R&D, investment, licensing 
partnerships and arrangements with Asia, North America, Europe and the Middle East. Due to the lack 
of expertise in Malaysia, local research institutes and universities should take approaches in 
collaboration or partnership with foreign institutes in term of technology transfer and 
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commercialization. This effort helps to build a foundation for a sustainable Malaysian agricultural 
biotechnology industry.  
In addition, the lack of well trained and experienced patent examiners in Malaysia Intellectual Property 
Corporation (MyIPO) determining the number of successful patents. It is suggested to setting up of an 
institute that can up-skill IP Agents in Malaysia (Innovating Malaysia, n.d.). The drafting of IP documents 
is a specialised skill that makes the critical difference between the successful granting of IP or its 
rejection. 
To date, Malaysia still heavily relaying on public, foreign and large companies R&D activities. The 
continued reliance on foreign technologies and foreign direct investment may have negative effects on 
the economy in the future as foreign companies may be more attracted to new markets which offer 
better returns for their investment.  It is important that governments in developing countries such as 
Malaysia to introduce some reforms to improve the Biotechnology products commercialization. The 
local companies have to emulate the methodologies, systems and processes of Multinational 
Corporations in order to shorten their learning curve. However, they should take into account for 
several factors, especially the need to attract and maintain foreign investments and at the same time 
the desire to encourage local domestic innovations. The government assist local innovators in all their 
efforts to file a patent. Nevertheless, this cannot ensure the successful commercialization of the patent 
and for that purpose; foreign companies may still be of some importance that has all the resources to 
commercialize it. By license out the technology to a foreign or local company, the local patent holder 
could get revenues from royalty fees and reinvest into local private R&D in order to eventually obtain 
new patents (Jusoh, 2006). 
5. CONCLUSION 
The Malaysian government plays direct role in promoting the commercialization of Biotechnology and 
Bioinformatics R&D products. Malaysia should improve its fundamental agendas in order to strive to be 
a knowledge and technology driven economy. A number of efforts have been taken to some extent 
supporting the shift of Malaysia to become a high-income economy based on Biotechnology and 
Bioinformatics. However, many challenges had been discovered such as the fund availability and support 
programmes that are spread over multiple agencies; industry and academia speaking “different 
languages”; national and international linkages; government agencies internal structure including 
transforming like fund managers and extracting more value from IP management. Further improvement 
is vital especially in our education system, research and development, and human capital to enhance the 
current R&D&C efforts. Moreover, Malaysia government should consolidate nation-wide policies with 
an integrated approach to support innovation and increase the success rate of Research, Development 
and Commercialization. 
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